RESUMEN
Traumatic plastic deformation is a rare occurrence in childhood and is exceptional during adult age. The authors report one case of the lesion occurring in a patient aged 20 years; they emphasize the need for adequate treatment, and formulate a pathogenetic hypothesis with a biomechanical basis.
Asunto(s)
Traumatismos del Antebrazo/etiología , Accidentes de Trabajo , Adulto , Anestesia General , Moldes Quirúrgicos , Antebrazo/diagnóstico por imagen , Traumatismos del Antebrazo/diagnóstico , Traumatismos del Antebrazo/terapia , Humanos , Masculino , Manipulación Ortopédica/métodos , Pronación , Radiografía , SupinaciónRESUMEN
The organization of the actin cytoskeleton is essential for several cellular processes. Here we report the characterization of a Saccharomyces cerevisiae novel gene, SDA1, encoding a highly conserved protein, which is essential for cell viability and is localized in the nucleus. Depletion or inactivation of Sda1 cause cell cycle arrest in G(1) by blocking both budding and DNA replication, without loss of viability. Furthermore, sda1-1 temperature-sensitive mutant cells arrest at the non-permissive temperature mostly without detectable structures of polymerized actin, although a normal actin protein level is maintained, indicating that Sda1 is required for proper organization of the actin cytoskeleton. To our knowledge, this is the first mutation shown to cause such a phenotype. Recovery of Sda1 activity restores proper assembly of actin structures, as well as budding and DNA replication. Furthermore we show that direct actin perturbation, either in sda1-1 or in cdc28-13 cells released from G(1) block, prevents recovery of budding and DNA replication. We also show that the block in G(1) caused by loss of Sda1 function is independent of Swe1. Altogether our results suggest that disruption of F-actin structure can block cell cycle progression in G(1) and that Sda1 is involved in the control of the actin cytoskeleton.
Asunto(s)
Actinas/fisiología , Proteínas de Ciclo Celular/genética , Ciclo Celular/genética , Citoesqueleto/genética , Proteínas Fúngicas/genética , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , Actinas/metabolismo , Secuencia de Aminoácidos , Ciclo Celular/fisiología , Proteínas de Ciclo Celular/biosíntesis , Proteínas de Ciclo Celular/fisiología , División Celular/genética , Quitina/metabolismo , Secuencia Conservada , Citoesqueleto/metabolismo , Citoesqueleto/fisiología , Replicación del ADN/genética , Endocitosis/genética , Proteínas Fúngicas/biosíntesis , Proteínas Fúngicas/fisiología , Fase G1/genética , Humanos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Proteínas Nucleares/biosíntesis , Proteínas Nucleares/genética , Proteínas Nucleares/fisiología , Proteínas Tirosina Quinasas/fisiología , Saccharomyces cerevisiae/citología , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/crecimiento & desarrollo , TemperaturaRESUMEN
GTP-cyclohydrolase I (GTP-CH1, EC 3.5.4.16) is encoded by the GCH1 gene. Mutations in the GCH1 gene cause both dopa-responsive dystonia (McKusick 128230) and recessive GTP-CH1 deficiency (McKusick 600225). The exact molecular mechanism resulting in decreased GTP-CH1 activity in the patients is still obscure. We report the clinical features and molecular and functional study of the GCH1 gene in eight Italian patients affected by dominant and recessive GTP-CH1 deficiency. All the studied patients had mutations in the GCH1 gene. Three missense mutations (V205G, K224R, P199A), a frameshift mutation (Delta G693), and a splice-site mutation (ivs5 + 1g > c) were found. Except for K224R these are all novel mutations. To analyse the defect caused by the novel mutations, an in vivo functional assay in a Saccharomyces cerevisiae strain lacking the endogenous gene encoding GTP-CH1 ( FOL2 ) was performed. Complementation analysis showed that the Delta G693 and V205G mutations abolish the enzymatic function, while the P199A mutation causes a conditional defect. In conclusion, the clinical phenotypes displayed by our patients confirm the wide clinical spectrum of the disease and further support the lack of correlation between a given mutation and a clinical phenotype. Complementation analysis in yeast is a useful tool for confirming the pathogenetic effect of GCH1 mutations.
Asunto(s)
GTP Ciclohidrolasa/deficiencia , GTP Ciclohidrolasa/genética , Mutación , Adulto , Femenino , Mutación del Sistema de Lectura , Humanos , Masculino , Mutagénesis Sitio-Dirigida , Mutación Missense , Reacción en Cadena de la Polimerasa , Saccharomyces cerevisiae/genéticaRESUMEN
Saccharomyces cerevisiae is so far the only organism where a knock-out mutant in the gene encoding GTP cyclohydrolase I (FOL2) has been obtained. GTP cyclohydrolase I controls the de novo biosynthetic pathway of tetrahydrobiopterin and folic acid. Since deletion of yeast FOL2 leads to a recessive auxotrophy for folinic acid, we used a yeast fol2Delta mutant for an in vivo functional assay of heterologous GTP cyclohydrolases I. We show that the GTP cyclohydrolase I, encoded either by the E. coli folE gene or by the human cDNA, complements the yeast fol2Delta mutation by restoring folate prototrophy. Furthermore the folE-3x allele of the E. coli gene, carrying three base substitutions, failed to complement the yeast fol2Delta defect. This allele behaved as a negative semidominant to the wild type folE and, when overexpressed, completely abolished complementation of fol2Delta by folE. Thus, the yeast fol2 null mutant is a suitable system to characterize mutations in genes encoding GTP cyclohydrolase I.